Cellectar Biosciences, Inc.
Clinical trials sponsored by Cellectar Biosciences, Inc., explained in plain language.
-
New radiation drug trial offers hope for kids with tough cancers
Disease control OngoingThis study is testing a new drug called CLR 131 in children and young adults whose cancers have come back or haven't responded to standard treatments. The drug is designed to deliver radiation directly to cancer cells. The main goals are to find a safe dose and see if the drug sh…
Phase: PHASE1 • Sponsor: Cellectar Biosciences, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New hope for kids with inoperable brain cancer: targeted radiation trial seeks to control tumors
Disease control OngoingThis early-stage study is testing a new targeted radiation drug called CLR 131 in children and young adults (ages 10-25) with aggressive brain tumors that have returned or not responded to other treatments and cannot be removed by surgery. The main goals are to find a safe and ef…
Phase: PHASE1 • Sponsor: Cellectar Biosciences, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Radioactive 'Tumor Seeker' drug tested as last hope for tough blood cancers
Disease control OngoingThis study is testing an experimental drug called iopofosine I 131 in people with various advanced B-cell blood cancers that have come back or stopped responding to standard treatments. The drug is designed to deliver radiation directly to cancer cells. The main goal is to see if…
Phase: PHASE2 • Sponsor: Cellectar Biosciences, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC